ArticleMolecules (Basel, Switzerland)2026
Amphiphilic Covalent Organic Framework for Efficient DHT Adsorption and Androgenetic Alopecia Treatment via Spectral Technology.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Androgenetic alopecia (AGA) is a prevalent clinical disorder, and the key pathogenic factor is dihydrotestosterone (DHT) present in the pilosebaceous unit. Current clinical therapeutic options are often associated with notable adverse effects, highlighting the urgent need for safer and more effective interventions. Herein, a novel amphiphilic covalent organic framework (amCOF) is designed and synthesized. By simultaneously incorporating hydrophilic functional groups and lipophilic alkyl chains into the covalent organic skeleton, the material exhibits excellent amphiphilicity, high specific surface area, and well-ordered porous structures. Owing to its amphiphilic nature, amCOF disperses uniformly in aqueous physiological media and adapts favorably to the lipophilic microenvironment within hair follicles. Furthermore, the ordered porous architecture endows amCOF with rapid DHT adsorption kinetics, high adsorption capacity, and high removal efficiency. Functional assays demonstrate that amCOF effectively reverses the inhibitory effects of DHT on the proliferation and migration of human dermal papilla cells. In animal models, topical application of amCOF significantly reduces local DHT concentrations, promotes hair regrowth, and shows favorable biosafety profiles. Collectively, this work provides a new strategy for treating androgenetic alopecia by scavenging pathogenic lipophilic molecules from sebum using amphiphilic porous materials and also establishes a solid foundation for expanding the biomedical applications of COFs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.